Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Branden J Stansley

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Current Opinion in Pharmacology|February 28, 2018
The therapeutic potential of metabotropic glutamate receptor modulation for schizophreniaBranden J Stansley, P Jeffrey Conn
Neuropharmacology|December 1, 2012
L-dopa-induced dopamine synthesis and oxidative stress in serotonergic cellsBranden J Stansley, Bryan K Yamamoto
The Journal of Pharmacology and Experimental Therapeutics|September 13, 2014
Chronic L-dopa decreases serotonin neurons in a subregion of the dorsal raphe nucleusBranden J Stansley, Bryan K Yamamoto
Trends in Pharmacological Sciences|March 3, 2019
Neuropharmacological Insight from Allosteric Modulation of mGlu ReceptorsBranden J Stansley, P Jeffrey Conn
Toxics|October 24, 2017
L-Dopa and Brain Serotonin System DysfunctionBranden J Stansley, Bryan K Yamamoto
Psychopharmacology|June 4, 2015
Behavioral impairments and serotonin reductions in rats after chronic L-dopaBranden J Stansley, Bryan K Yamamoto
Cerebral Cortex (New York, N.Y. : 1991)|November 15, 2017
Contextual Fear Extinction Induces Hippocampal Metaplasticity Mediated by Metabotropic Glutamate Receptor 5Branden J Stansley, Nicole M Fisher, Rocco G Gogliotti, et al.
ACS Chemical Neuroscience|December 12, 2017
Genetic Reduction or Negative Modulation of mGlu<sub>7</sub> Does Not Impact Anxiety and Fear Learning Phenotypes in a Mouse Model of MECP2 Duplication SyndromeNicole M Fisher, Rocco G Gogliotti, Sheryl Anne D Vermudez, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 11, 2018
Total RNA Sequencing of Rett Syndrome Autopsy Samples Identifies the M<sub>4</sub> Muscarinic Receptor as a Novel Therapeutic TargetRocco G Gogliotti, Nicole M Fisher, Branden J Stansley, et al.
ACS Pharmacology & Translational Science|July 2, 2019
mGlu<sub>5</sub> Positive Allosteric Modulators Facilitate Long-Term Potentiation via Disinhibition Mediated by mGlu<sub>5</sub>-Endocannabinoid SignalingZixiu Xiang, Xiaohui Lv, James Maksymetz, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Current Opinion in Pharmacology|February 28, 2018
The therapeutic potential of metabotropic glutamate receptor modulation for schizophreniaBranden J Stansley, P Jeffrey Conn
Neuropharmacology|December 1, 2012
L-dopa-induced dopamine synthesis and oxidative stress in serotonergic cellsBranden J Stansley, Bryan K Yamamoto
The Journal of Pharmacology and Experimental Therapeutics|September 13, 2014
Chronic L-dopa decreases serotonin neurons in a subregion of the dorsal raphe nucleusBranden J Stansley, Bryan K Yamamoto
Trends in Pharmacological Sciences|March 3, 2019
Neuropharmacological Insight from Allosteric Modulation of mGlu ReceptorsBranden J Stansley, P Jeffrey Conn
Toxics|October 24, 2017
L-Dopa and Brain Serotonin System DysfunctionBranden J Stansley, Bryan K Yamamoto
Psychopharmacology|June 4, 2015
Behavioral impairments and serotonin reductions in rats after chronic L-dopaBranden J Stansley, Bryan K Yamamoto
Cerebral Cortex (New York, N.Y. : 1991)|November 15, 2017
Contextual Fear Extinction Induces Hippocampal Metaplasticity Mediated by Metabotropic Glutamate Receptor 5Branden J Stansley, Nicole M Fisher, Rocco G Gogliotti, et al.
ACS Chemical Neuroscience|December 12, 2017
Genetic Reduction or Negative Modulation of mGlu<sub>7</sub> Does Not Impact Anxiety and Fear Learning Phenotypes in a Mouse Model of MECP2 Duplication SyndromeNicole M Fisher, Rocco G Gogliotti, Sheryl Anne D Vermudez, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 11, 2018
Total RNA Sequencing of Rett Syndrome Autopsy Samples Identifies the M<sub>4</sub> Muscarinic Receptor as a Novel Therapeutic TargetRocco G Gogliotti, Nicole M Fisher, Branden J Stansley, et al.
ACS Pharmacology & Translational Science|July 2, 2019
mGlu<sub>5</sub> Positive Allosteric Modulators Facilitate Long-Term Potentiation via Disinhibition Mediated by mGlu<sub>5</sub>-Endocannabinoid SignalingZixiu Xiang, Xiaohui Lv, James Maksymetz, et al.
Pageof 2